Longitudinal Changes in Characteristics of COVID-19 Survivors and Their Long-term Follow-up Study
NCT ID: NCT05004246
Last Updated: 2024-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
1000 participants
OBSERVATIONAL
2021-03-15
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comorbidities And Complications Associated With Covid-19 Infection
NCT04563442
Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
NCT04279782
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
NCT04368221
Post Acute Sequelae of COVID-19
NCT04964115
Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors.
NCT05185674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Yichang Central People's Hospital
OTHER
First Affiliated Hospital of Wenzhou Medical University
OTHER
Xiangya Hospital of Central South University
OTHER
Yunnan Provincial Infectious Disease Hospital
OTHER
WUHAN Number Seven HOSPITAL
UNKNOWN
Shanxi Bethune Hospital
OTHER
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qin Ning
Director of Department of Infectious Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of infectious disease, Tongji Hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TJ20210622
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.